Atara Biotherapeutics Announces First Quarter 2021 Financial Results and Operational Progress

Go back to Atara Biotherapeutics Announces First Quarter 2021 Financial Results and Operational Progress

ATARA Biotherapeutics (ATRA) Tops Q1 EPS by 6c

May 4, 2021 4:17 PM EDT

ATARA Biotherapeutics (NASDAQ: ATRA) reported Q1 EPS of ($0.86), $0.06 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $3.55 million versus the consensus estimate of $1.6 million.

For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.

... More